There is ample evidence for a significant impact of murine Car activation on hypercholesterolemia and cholesterol homeostasis in various animal models of hypercholesterolemia; however, clinical data are lacking, as there is no known CAR ligand for human therapy. This evidence concerns the gene CXADR and Hypercholesterolemia.